Garden Stage (GSIW) Competitors $0.55 0.00 (-0.07%) (As of 05:26 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrends GSIW vs. MLEC, GLST, GROW, MCAG, MARX, QOMO, PPHP, AQU, NYC, and SOHOShould you be buying Garden Stage stock or one of its competitors? The main competitors of Garden Stage include Moolec Science (MLEC), Global Star Acquisition (GLST), U.S. Global Investors (GROW), Mountain Crest Acquisition Corp. V (MCAG), Mars Acquisition (MARX), Qomolangma Acquisition (QOMO), PHP Ventures Acquisition (PPHP), Aquaron Acquisition (AQU), American Strategic Investment (NYC), and Sotherly Hotels (SOHO). These companies are all part of the "trading" industry. Garden Stage vs. Moolec Science Global Star Acquisition U.S. Global Investors Mountain Crest Acquisition Corp. V Mars Acquisition Qomolangma Acquisition PHP Ventures Acquisition Aquaron Acquisition American Strategic Investment Sotherly Hotels Garden Stage (NASDAQ:GSIW) and Moolec Science (NASDAQ:MLEC) are both small-cap finance companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, dividends, valuation, analyst recommendations, profitability, risk, media sentiment, earnings and institutional ownership. Which has preferable earnings & valuation, GSIW or MLEC? Garden Stage has higher earnings, but lower revenue than Moolec Science. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGarden Stage$1.36M6.04-$4.59MN/AN/AMoolec Science$5.63M5.40-$7.31M-$0.20-3.95 Does the media prefer GSIW or MLEC? In the previous week, Garden Stage's average media sentiment score of 0.00 equaled Moolec Science'saverage media sentiment score. Company Overall Sentiment Garden Stage Neutral Moolec Science Neutral Do analysts recommend GSIW or MLEC? Moolec Science has a consensus price target of $6.00, suggesting a potential upside of 659.40%. Given Moolec Science's stronger consensus rating and higher possible upside, analysts plainly believe Moolec Science is more favorable than Garden Stage.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Garden Stage 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Moolec Science 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community believe in GSIW or MLEC? Moolec Science received 3 more outperform votes than Garden Stage when rated by MarketBeat users. CompanyUnderperformOutperformGarden StageN/AN/AMoolec ScienceOutperform Votes3100.00% Underperform VotesNo Votes Do insiders & institutionals have more ownership in GSIW or MLEC? 0.5% of Garden Stage shares are owned by institutional investors. Comparatively, 0.1% of Moolec Science shares are owned by institutional investors. 19.9% of Moolec Science shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is GSIW or MLEC more profitable? Garden Stage has a net margin of 0.00% compared to Moolec Science's net margin of -129.97%. Garden Stage's return on equity of 0.00% beat Moolec Science's return on equity.Company Net Margins Return on Equity Return on Assets Garden StageN/A N/A N/A Moolec Science -129.97%-97.95%-27.91% SummaryGarden Stage and Moolec Science tied by winning 6 of the 12 factors compared between the two stocks. Ad WealthPress70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today!Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.>> You can grab your FREE, laminated copies right here << Get Garden Stage News Delivered to You Automatically Sign up to receive the latest news and ratings for GSIW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GSIW vs. The Competition Export to ExcelMetricGarden StageSecurity & commodity brokers IndustryFinance SectorNASDAQ ExchangeMarket Cap$8.24M$26.41B$11.37B$9.13BDividend YieldN/A1.42%5.68%4.26%P/E RatioN/A20.3824.9817.15Price / Sales6.046.2326.46118.46Price / CashN/A22.7618.5137.85Price / Book0.864.932.624.78Net Income-$4.59M$909.38M$1.04B$225.50M7 Day Performance-8.20%-2.58%-3.04%-1.00%1 Month Performance-20.96%-5.10%-3.72%0.67%1 Year Performance-93.11%4.79%10.79%15.58% Garden Stage Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GSIWGarden StageN/A$0.55-0.1%N/A-92.8%$8.62M$1.36M0.0013MLECMoolec Science1.6879 of 5 stars$0.87+1.2%$6.00+589.7%-64.9%$33.44M$5.63M-4.304Positive NewsGap DownGLSTGlobal Star AcquisitionN/A$11.33-4.8%N/A+7.6%$33.00MN/A0.00N/APositive NewsGROWU.S. Global Investors3.2403 of 5 stars$2.42-0.4%N/A-14.4%$32.73M$10.01M18.7720Dividend AnnouncementAnalyst ForecastNews CoverageMCAGMountain Crest Acquisition Corp. VN/A$11.190.0%N/AN/A$32.47MN/A0.001MARXMars AcquisitionN/A$6.81-0.3%N/A-56.0%$30.46MN/A0.00N/AGap UpTrading HaltedQOMOQomolangma AcquisitionN/A$11.55+0.9%N/AN/A$28.88MN/A0.00N/APPHPPHP Ventures AcquisitionN/A$11.07flatN/AN/A$28.75MN/A-27.683AQUAquaron AcquisitionN/A$11.26+0.9%N/A+8.0%$27.34MN/A0.00N/AGap UpNYCAmerican Strategic Investment1.7232 of 5 stars$9.15+5.8%N/A+12.4%$24.34M$62.71M0.00N/AGap DownSOHOSotherly Hotels3.3202 of 5 stars$1.05+0.8%$1.50+42.9%-35.0%$20.84M$180.09M-3.1610Analyst ForecastNews CoverageGap Down Related Companies and Tools Related Companies MLEC Alternatives GLST Alternatives GROW Alternatives MCAG Alternatives MARX Alternatives QOMO Alternatives PPHP Alternatives AQU Alternatives NYC Alternatives SOHO Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:GSIW) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Garden Stage Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Garden Stage With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
